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The aim of this study was to evaluate prognostic and/or 
diagnostic factors of canine mammary tumors by immuno-
histochemically  analyzing  the  expression  of  alpha  basic 
crystallin (αB-c). For this, formalin-fixed, paraffin-embedded 
blocks of 51 naturally-occurring canine mammary tumors 
(11 benign and 40 malignant) were used. Tissue from eight 
normal canine mammary glands were served as a control. 
Immunohistochemically, in the control mammary tissues, a 
few luminal epithelial cells were αB-c positive but myoepithelial 
cells were negative.  In benign or simple type malignant tumors, 
αB-c expression was observed in luminal epithelial cells 
while the myoepithelial basal cells were negative. In benign 
or  complex  type  malign  tumors,  positive  staining  was 
predominantly found in the cytoplasm of epithelial cells. 
Immunoreactivity of αB-c was also observed in neoplastic 
myoepithelial cells. Statistically, the number of cells immuno-
labeled with αB-c was found to be significantly different 
among  tissues  from  normal  canine  mammary  glands, 
benign  lesions,  and  malignant  tumors  (p <  0 . 0 5 ) .  αB-c 
immunoreactivity was higher in malignant tumors than the 
control mammary tissues (p < 0.001). Data obtained in the 
current study revealed a strong association between high 
expression  levels  of  αB-c  and  primary  mammary  gland 
tumors in canines.
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Introduction
Heat shock proteins (HSPs) or stress proteins, which play 
an essential role in the maintenance of cellular home-
ostasis, are the products of several distinct gene families 
produced under both physiological and stress conditions 
[2]. Alpha basic-crystallin (αB-c)  belongs to a family of 
small HSPs, and is expressed in response to different 
stresses including heat shock, oxidative stress, metal ions, 
and cytokines [6,11].  αB-c is constitutively expressed in 
many humans and animals tissues such as the lens of the 
eyes, heart, and skeletal muscle [9,16]. αB-c has 
chaperone-like properties which prevent the aggregation 
of damaged or proteins misfolded due to cell stress, and has 
been shown to inhibit apoptosis [10].
Mammary tumors, the most common neoplasms in 
female dogs, may provide a useful model for human breast 
cancer research [15]. Both benign and malignant neoplasms 
account for approximately 50% of all tumors in dogs and 
show wide pathological and clinical heterogeneity [12,18]. 
After surgical intervention, approximately 48% of the 
affected dogs die or are euthanized within a 1-year period 
because of tumor recurrence or metastasis [7]. Therefore, 
additional and reliable prognostic tools are required for 
effective risk assessment. The aims of this study were to 
evaluate the prognostic and/or diagnostic factors associated 
with canine mammary tumors in dogs by analyzing the 
immunohistochemical expression of αB-c.
Materials and Methods
Formalin-fixed, paraffin-embedded blocks containing 51 
naturally occurring canine mammary tumors (11 benign 
and 40 malignant) were selected retrospectively and 
acquired from the Veterinary Laboratory (Italy) and 
Department of Pathology, Faculty of Veterinary Medicine, 
Ondokuz Mayis University (Turkey). Additionally, eight 
normal canine mammary glands obtained from the dogs 
that had died of causes unrelated to tumor development 
served as healthy control tissues. Three pathologists (TG, 
MYG and MS) independently diagnosed the tumors 
according to the World Health Organization classifications 
for canine mammary neoplasm [13].  
Sections from all the tissue samples were cut (at a 40    Tolga Guvenc et al.
Table 1. Results of immunohistochemical staining for alpha basic crystallin (αB-c) expression and histopathologic diagnoses
Histopathologic diagnoses
Number of
samples
Number and percent of samples for each αB-c immunoreactivity score
0* 1
† 2
‡ 3
§
Malignant lesions 40 3 (7.5%) 10 (25%) 12 (30%) 15 (37.5%)
Complex carcinoma 14 򰠏   3 (21.4%)   5 (35.7%)   6 (42.9%)
Carcinosarcoma  8 1 (12.5%)   1 (12.5%)   3 (37.5%)   3 (37.5%)
Tubulopapillary carcinoma 11 1 (9.1%)   3 (27.3%)   3 (27.3%)   4 (36.3%)
Spindle carcinoma  5 1 (20%)   2 (40%)   1 (20%)   1 (20%)
Simple carcinoma  2 򰠏   1 (50%) 򰠏   1 (50%)
Benign lesions 11 3 (27.3%)   5 (45.4%)   2 (18.2%)   1 (9.1%)
Complex adenoma  4 򰠏   2 (50%)   1 (25%)   1 (25%)
Simple adenoma  3 1 (33.3%)   1 (33.3%)   1 (33.3%) 򰠏
Benign mixed tumor  2 1 (50%)   1 (50%) 򰠏򰠏
Hyperplasia  2 1 (50%)   1 (50%) 򰠏򰠏
*0: no positively stained tumor cells; 
†5∼25%; 
‡26∼50%; 
§greater than 51% positive tumor cells.
Fig. 1. (A) Some alpha basic crystallin (αB-c)-positive 
immunoreaction observed at the luminal epithelial cells in the 
control mammary tissues (arrows); myoepithelial cells were 
negative. (B) αB-c-immunopositive reaction of the luminal 
epithelial cells of the simple adenoma (arrows). (C) In the complex
adenocarcinoma, positive staining was predominantly found in 
the cytoplasm of neoplastic epithelial cells and, to a lesser extent,
in the neoplastic myoepithelial cells. (D) In carcinosarcoma, no 
immunopositive reaction was observed in the mesenchymal 
elements (me), but positive staining was seen in the neoplastic 
epithelial cells. Immunohistochemical staining was performed 
with streptavidin- biotin-peroxidase and amino ethyl carbazole 
chromogen. A: × 220, B and C: × 140, D: × 90.
thickness of 4 μm) and stained with haematoxylin and 
eosin. Additional sections were placed on slides coated 
with 3-aminopropyltriethoxysilane (Sigma, USA) and 
stained using a streptavidin-biotin-peroxidase complex 
technique (Histostain Plus kit; Zymed, USA) with a 
monoclonal anti-αB-c antibody (1/1,000 dilution, SPA- 
222; Stressgen, Canada). Incubation with amino ethyl 
carbazole (AEC substrate kit; Invitrogen, USA) or 3,3’- 
diaminobenzidine (DAB chromogen/substrate kit; Scytek, 
USA) as a chromogen in H2O2 was performed for 10 min. 
The sections were counterstained with Mayer’s hematoxylin 
for 1 min, rinsed with tap water, and mounted with an 
aqueous mounting medium (Vision Mount; Lab Vision, 
USA).  
The percentages of the total area of the immunohisto-
chemically positive cells were assessed with a microscopy 
image analysis system (Bs200P; BAB Software, Turkey). 
A total of 10 high-power fields were randomly chosen and 
analyzed at × 400. The findings were categorized as 
follows: (0) no positively stained tumor cells; (1) 5∼25%; 
(2) 26∼50%; and (3) greater than 51% positive tumor 
cells. Statistical analysis was carried out using a logistic 
regression analysis. The results were considered statistically 
significant if p < 0.05. 
Results
The immunohistochemical results of αB-c expression 
and histopathologic diagnoses are summarized in Table 1. 
In the control mammary tissues, a few luminal epithelial 
cells were positive but the basal myoepithelial cells were 
negative (Fig. 1A). Muscles (e.g., M. supramammarius) 
were always positive and were used as positive internal 
controls when present.
In benign or malignant simple type tumors, αB-c ex-
pression was observed in the luminal epithelial cells (Fig. 
1B) while the myoepithelial cells were negative. Addi-αB-crystallin canine mammaryitle    41
tionally, αB-c immunoreactivity of the epithelial cells in 
malignant tumors was more intense than that observed in 
the benign type. In both benign and malignant complex 
type tumors, positive staining was noted predominantly in 
the cytoplasm of the neoplastic epithelial cells (Fig. 1C). 
αB-c immunoreactivity was also found in neoplastic 
myoepithelial cells. However, αB-c-positive mesenchymal 
elements of the carcinosarcoma, such as cartilage or bone, 
were not observed (Fig. 1D). 
The numbers of αB-c positive cells were statistically 
significant different between the control canine mammary 
tissues and benign tumors (p < 0.05). Statistically, signi-
ficant differences of αB-c immunopositive cells were also 
found in between benign and malignant tumors (p < 0.05). 
Additionally, the most significant difference of immuno-
positive cell count was observed between normal mammary 
gland tissues and malignant tumors (p < 0.001).  
Discussion 
The results of the current study indicates that the number 
of  αB-c-positive cells were increased in benign and 
malignant canine mammary tumors when compared to 
control mammary gland, and the number of αB-c-positive 
cells were higher in malignant tumors when compared with 
benign tumors.
αB-c is a member of the mammalian small HSP 
superfamily [8]. This factor is expressed in many tissues 
and organs, and acts as a molecular chaperon. It is 
upregulated by physiologic stress and neurodegenerative 
diseases [1,5,8,16]. Additionally, αB-c is expressed in 
breast and the other cancers, such as gliomas, and prostate 
and renal cell carcinomas, in humans [3,4,14,19]. However, 
the best of our knowledge, there is no such study performed 
in animals and the present report documents a connection 
between αB-c and mammary tumors in canines.  
In the normal human breast tissue, αB-c is predominantly 
expressed in myoepithelial cell [14]. In contrast to this 
report, in the current study, very low level expression of 
αB-c was observed in the luminal epithelial cells of normal 
canine mammary tissues, but αB-c immunepositive reac-
tivity in the myoepithelial cells was not observed. It is 
possible that this difference might be species-specific or 
related to the physiological stage of the control mammary 
gland tissues. Sitterding et al. [17] reported that αB-c may 
be used as a myoepithelial marker, but it does not have any 
special advantage over currently used markers such as 
smooth muscle myosine. In contrast, αB-c immune 
reactivity in the myoepithelial cells was not observed in 
our study. Therefore, αB-c immunostaining in the canine 
mammary gland tissues could not be suggested as a 
myoepithelial marker. 
Chelouche-Lev et al. [3] have reported that out of 672 
human breast tumors, 608 (90%) are positive for αB-c 
immunostaining. In contrast, Moyano et al. [14] noted 39 
positively immunostained samples out of 361 (11%) 
human breast cancer cases. Sitterding et al. [17] reported 
that  αB-c expression is observed in human basal-like 
(81%) and metaplastic (86%) breast cancer. In the present 
study, the rate of αB-c expression in canine mammary 
gland tumors was 88.2% (45 out of 51). Although it is 
difficult to compare canines to humans, our data are similar 
to the findings of Chelouche-Lev et al. [3] and Sitterding et 
al. [17], but different from those of Moyano et al. [14].  
Differences in the number of αB-c-immunolabelled cells 
were found to be statistically significant between the 
normal canine mammary tissues and the benign and malig-
nant tumors. These differences were thought to be evidence 
that αB-c was involved in oncogenesis because of the 
anti-apoptotic effect of αB-c. This effect probably involves 
the suppression of caspase-3 activation and/or preventing 
the mitochondrial translocation of pro-apoptotic Bcl-2 
family members such as Bax [10]. 
In conclusion, we believe that αB-c can play a role in the 
carcinogenesis of canine mammary glands because of the 
increased immunoreactivity of αB-c we observed in 
neoplastic tissues compared to the normal canine mammary 
gland tissues. αB-c has an anti-apoptotic effect and this 
anti-apoptotic effect can be important in chemotherapy 
resistance of the cancer. Additionally, targeted inhibition 
of αB-c may be a new strategy to the cancer therapy.
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